Walk into Purecell
Purecell Biomedical is located in the Soaring Innovation Park of Suzhou Industrial Park. It is dedicated to the research and development and clinical application of stem cell and immune cell technology, and creates an industrial chain integrating advanced cell research and development, clinical research and marketing. . We have built a 1000m² GMP Class 100 clean room and a 4000m² R&D laboratory to carry out research and development of new technologies for stem cells and immune cells and clinical research on stem cell new drugs. At the same time, we have built a human tissue cell bank of 1 million people.
Puricon mainly focuses on the standardized preparation of various stem cells (umbilical cord mesenchymal stem cells, adipose stem cells, placental stem cells, amniotic stem cells, deciduous stem cells, etc.), conducts stem cell clinical research, and declares new stem cell drugs. At present, the clinical research work of "Umbilical cord mesenchymal stem cells for decompensated hepatitis B cirrhosis" and "Umbilical cord mesenchymal stem cells combined with biomaterials for the treatment of degenerative knee arthritis" is being actively promoted. The corresponding animal experiments and clinical research are rapidly advancing. in. In the field of immunocell tumor treatment, the research and development of new technologies are actively deployed. The immune cell technologies such as NK, mTCM and ACTL are mature and perfect. The CAR-T technology has been clinically proven, and the efficacy is comparable to that of foreign counterparts. Universal CART technology is being developed. Also actively carry out cells.Development and application of medical beauty anti-aging technology, functional medical testing services, stem cell active factor RE series and other products and technologies.
Jiangsu Precon Biomedicine adheres to the corporate tenet of “Puji Zhongsheng, Ruize Tianxia, Kangfu Wanjia”, and actively carries out research on universal cell drugs and standardized large-scale cell preparation. With intellectual property rights in key cell technologies, a regional R&D base, a first-rate network of treatment centers and international brands, an international anti-aging center, and a human tissue cell bank that meets the needs of Chinese people for treatment and prevention. Committed to becoming a world-class cell technology company within 2-3 years.